Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-8-2
pubmed:abstractText
MHC class I-restricted CD8(+) T cells are necessary to mount an immune response against Mycobacterium tuberculosis. M. tuberculosis antigens can enter MHC class I cross-processing pathways through a number of different mechanisms, including via the uptake of antigen-containing apoptotic vesicles released by infected cells. A study in this issue of the JCI by Hinchey and colleagues shows that M. tuberculosis inhibits host cell apoptosis and thus may interfere with optimal cross-priming and action of CD8(+) T cells (see the related article beginning on page 2279). M. tuberculosis genetically modified to induce apoptosis is shown to be more effective in priming CD8(+) T cells in vivo and therefore may be a more effective vaccine against tuberculosis than the currently utilized M. bovis BCG vaccine.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-10399077, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-12368425, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-12654780, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-12675804, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-12758197, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-14515128, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-15187142, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-15385521, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-15502839, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-16110326, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-16214599, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-16413927, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-16513383, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-16547267, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-17044198, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-17046678, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-17160001, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-17671656, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-7596718, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-8287475, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-8309034, http://linkedlifedata.com/resource/pubmed/commentcorrection/17671648-9886409
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2092-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
New TB vaccines: is there a requirement for CD8 T cells?
pubmed:affiliation
Tuberculosis Research Unit, Case Western Reserve University and University Hospitals' Case Medical Center, Cleveland, Ohio 44106-4984, USA. whb@case.edu
pubmed:publicationType
Journal Article, Comment, Research Support, N.I.H., Extramural